Evaluation of the Case–Crossover (CCO) Study Design for Adverse Drug Event Detection

Evaluation of the Case–Crossover (CCO) Study Design for Adverse Drug Event Detection Drug Saf (2017) 40:789–798 DOI 10.1007/s40264-017-0540-3 OR IGINAL RESEARCH ARTIC L E Evaluation of the Case–Crossover (CCO) Study Design for Adverse Drug Event Detection 1 1 1 1 • • • • Zachary Burningham Tao He Chia-Chen Teng Xi Zhou 1 1 Jonathan Nebeker Brian C. Sauer Published online: 4 May 2017 Springer International Publishing Switzerland 2017 Abstract 360-day window length. The AUC for the accumulative Introduction The case–crossover (CCO) design was orig- outcomes increased with longer risk and control windows inally intended to study exposures characterized as inter- and stronger simulated RR. For example, the AUC for the mittent with acute effects. The performance of the CCO simulated RR of 4 was 0.85 for a 360-day window length design is not well characterized under alternative exposure and 0.23 for a 30-day window length. Risk and control and outcome relationships. window lengths did not appear to sufficiently alter the Objective The purpose of this study was to evaluate the AUC for insidious onset outcomes. ability of the CCO to identify simulated treatment effects Conclusions The CCO performed best for acute-onset under different drug exposures and outcomes relationships outcomes, but may be useful for exploring adverse out- while varying the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drug Safety Springer Journals

Evaluation of the Case–Crossover (CCO) Study Design for Adverse Drug Event Detection

Loading next page...
 
/lp/springer_journal/evaluation-of-the-case-crossover-cco-study-design-for-adverse-drug-yWYczulS8i
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-5916
eISSN
1179-1942
D.O.I.
10.1007/s40264-017-0540-3
Publisher site
See Article on Publisher Site

Abstract

Drug Saf (2017) 40:789–798 DOI 10.1007/s40264-017-0540-3 OR IGINAL RESEARCH ARTIC L E Evaluation of the Case–Crossover (CCO) Study Design for Adverse Drug Event Detection 1 1 1 1 • • • • Zachary Burningham Tao He Chia-Chen Teng Xi Zhou 1 1 Jonathan Nebeker Brian C. Sauer Published online: 4 May 2017 Springer International Publishing Switzerland 2017 Abstract 360-day window length. The AUC for the accumulative Introduction The case–crossover (CCO) design was orig- outcomes increased with longer risk and control windows inally intended to study exposures characterized as inter- and stronger simulated RR. For example, the AUC for the mittent with acute effects. The performance of the CCO simulated RR of 4 was 0.85 for a 360-day window length design is not well characterized under alternative exposure and 0.23 for a 30-day window length. Risk and control and outcome relationships. window lengths did not appear to sufficiently alter the Objective The purpose of this study was to evaluate the AUC for insidious onset outcomes. ability of the CCO to identify simulated treatment effects Conclusions The CCO performed best for acute-onset under different drug exposures and outcomes relationships outcomes, but may be useful for exploring adverse out- while varying the

Journal

Drug SafetySpringer Journals

Published: May 4, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off